Benefit-Risk Profile of DAPT Continuation Beyond 1 Year after PCI in Patients with High Thrombotic Risk Features as Endorsed by 2018 ESC/EACTS Myocardial Revascularization Guideline.

导出原文传递

翻译打印收藏纠错

第一作者： Hao-Yu,Wang

第一单位： Department of Cardiology, Coronary Heart Disease Center, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.;State Key Laboratory of Cardiovascular Disease, Beijing, China.;National Clinical Research Center for Cardiovascular Diseases, Beijing, China.

作者： Hao-Yu,Wang ^[1] ; Ke-Fei,Dou ^[2] ; Yang,Wang ^[3] ; Dong,Yin ^[4] ; Bo,Xu ^[5] ; Run-Lin,Gao ^[4]

作者单位： Department of Cardiology, Coronary Heart Disease Center, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.;State Key Laboratory of Cardiovascular Disease, Beijing, China.;National Clinical Research Center for Cardiovascular Diseases, Beijing, China. ^[1] Department of Cardiology, Coronary Heart Disease Center, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China. doukefei@fuwaihospital.org.;State Key Laboratory of Cardiovascular Disease, Beijing, China. doukefei@fuwaihospital.org.;National Clinical Research Center for Cardiovascular Diseases, Beijing, China. doukefei@fuwaihospital.org. ^[2] Medical Research and Biometrics Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. ^[3] Department of Cardiology, Coronary Heart Disease Center, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.;National Clinical Research Center for Cardiovascular Diseases, Beijing, China. ^[4] National Clinical Research Center for Cardiovascular Diseases, Beijing, China.;Catheterization Laboratories, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. ^[5]

关键词 Bleeding Drug-eluting stents Dual antiplatelet therapy High thrombotic risk Percutaneous coronary intervention Risk assessment